Hait Bio: The key task for 2026 is to promote the construction of additional production capacity of Epinamin.

At a recent performance briefing, Hait Bio stated that Epnai has now entered medical insurance, and by 2026, it has basically achieved full production and sales status. The company's key task in 2026 is to promote the construction of new production capacity for Epnai.